Zacks downgrades Octave Specialty Group stock to Strong Sell

Published on 10/16/2026 at 02:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter loss reached USD 14.429 million, versus USD 6.851 million in the first quarter. The target for Octave Specialty Group stock is USD 11.50.

Analyst downgrade and quarterly loss

Zacks Research cut the rating from Hold to Strong Sell on October 7, 2026.
Revenue reached USD 83.00 million in the latest reported quarter versus USD 22.79 million expected.
Market capitalization stood at USD 207.2 million, while the 52-week range was USD 3.88 to USD 10.38.

OSG, US69036R8631, Illustration mit AI erstellt.

Octave Specialty Group (ISIN US69036R8631) faced a sharper analyst stance on October 7, 2026, when Zacks Research cut its rating from Hold to Strong Sell, according to MarketBeat. The report placed the broader analyst consensus at Hold with a USD 11.50 target.

Rating pressure meets a loss

The downgrade came after the company reported a loss of USD 0.04 in earnings per share for its latest reported quarter, missing the USD 0.01 consensus loss estimate by USD 0.03, MarketBeat reported on October 7, 2026. Revenue reached USD 83.00 million, compared with analyst estimates of USD 22.79 million. The revenue gap and the earnings shortfall point in different directions, leaving profitability as the more immediate issue for the stock.

What does the target imply?

The USD 11.50 consensus target is materially above the reported USD 4.60 NYSE quote, but the target is not the same as a new recommendation. MarketBeat also reported that Keefe, Bruyette and Woods began coverage with an Outperform rating and a USD 8.00 target on August 28, 2026. That range shows why the rating picture is mixed even though the overall consensus remains Hold.

Octave Specialty Group operates as a specialty insurance platform focused on insurance distribution and underwriting. Its current profile places it in Financial Services and the Insurance - Specialty industry. The company reported total assets of USD 2.28 billion for the second quarter of 2026, while operating cash flow was negative USD 41.40 million in the same period.

Losses define the investor debate

The stock's market capitalization was USD 207.2 million on October 15, 2026. Its 52-week range was USD 3.88 to USD 10.38, leaving the reported USD 4.60 quote near the lower end of that span. The valuation debate therefore depends less on revenue scale than on whether the insurance platform can convert revenue into sustainable earnings.

Stock and reporting context

The last quoted NYSE price was USD 4.60 on October 15, 2026 at 4:00 p.m. EDT. The next important benchmark is a new quarterly report, with the second-quarter figures showing revenue of USD 83.00 million and a loss of USD 0.04 per share.